These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 5212521)

  • 1. [A syndrome of hematological changes in cancer of the prostate gland].
    Rupniewska ZM; Czarkowska D; Miturzyńska-Stryjecka H
    Pol Tyg Lek; 1969 Dec; 24(48):1858-9. PubMed ID: 5212521
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acute defibrination syndrome caused by prostatic adenocarcinoma].
    Kovács E; Petri B; Bajusz V
    Orv Hetil; 1969 Oct; 110(40):2346-7. PubMed ID: 5354129
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hemorrhage into the brain in cancer of the stomach].
    Beliavskaia KB
    Vrach Delo; 1968 Nov; 11():138-40. PubMed ID: 5744891
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostatic meningeal carcinomatosis with low serum level of prostate-specific antigen.
    Honda M; Miyagawa I
    Urology; 2005 Dec; 66(6):1320. PubMed ID: 16360475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [On the problem of pathogenic mechanism of hemorrhagic neurological complications in leukemia].
    Chmielewski T
    Wiad Lek; 1966 Aug; 19(15):1161-4. PubMed ID: 5231665
    [No Abstract]   [Full Text] [Related]  

  • 6. High dose hook effect in serum total and free prostate specific antigen in a patient with metastatic prostate cancer.
    Furuya Y; Cho S; Ohta S; Sato N; Kotake T; Masai M
    J Urol; 2001 Jul; 166(1):213. PubMed ID: 11435864
    [No Abstract]   [Full Text] [Related]  

  • 7. Skin metastasis of prostate adenocarcinoma to glans penis showing no correlation with serum prostate-specific antigen level.
    Kobashi-Katoh R; Tanioka M; Takahashi K; Miyachi Y
    J Dermatol; 2009 Feb; 36(2):106-8. PubMed ID: 19284456
    [No Abstract]   [Full Text] [Related]  

  • 8. [PSA and hormone-refractory period in prostatic cancer].
    Ojea Calvo A; Verez M; Alonso A; Rodríguez B; Domínguez F; Benavente J; Barros JM; Nogueira March JL
    Actas Urol Esp; 1996 Feb; 20(2):168-71. PubMed ID: 8677815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinogenopenia, bleeding and intravascular coagulation in cancer of the prostate. Report of a case.
    Andersson L; Kjellstrand CM; Saldeen T; Forkman A
    Acta Chir Scand; 1966 Oct; 132(4):466-75. PubMed ID: 5298247
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diferelin treatment of primary local and generalized cancer of the prostate].
    Kolesnikov GP; Rusakov IG; Shaplygin LV; Voznesenskiĭ SA; Bystrov AA
    Urologiia; 2001; (6):17-9. PubMed ID: 11785073
    [No Abstract]   [Full Text] [Related]  

  • 11. [Carcinoma of the prostate. Hemorrhagic diathesis caused by hyperfibrinolysis].
    Surós J; Foz M
    Med Clin (Barc); 1965 Apr; 44(4):259-61. PubMed ID: 5834019
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hemorrhages following repeated exchange transfusions].
    Turay P; Korill F; Vas M
    Kinderarztl Prax; 1974 May; 42(5):66-8. PubMed ID: 4848860
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of low prostate specific antigen on prostate cancer--a rare case report.
    Schneider HB
    Eur J Med Res; 2007 Jul; 12(7):311-3. PubMed ID: 17933704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyridinoline cross-linked carboxyterminal telopeptide of type I collagen as a useful marker for monitoring metastatic bone activity in men with prostate cancer.
    Noguchi M; Noda S
    J Urol; 2001 Sep; 166(3):1106-10. PubMed ID: 11490307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unfavorable prognostic value of human PEDF decreased in high-grade prostatic intraepithelial neoplasia: a differential proteomics approach.
    Qingyi Z; Lin Y; Junhong W; Jian S; Weizhou H; Long M; Zeyu S; Xiaojian G
    Cancer Invest; 2009 Aug; 27(7):794-801. PubMed ID: 19637042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastasectomy for isolated bilateral adrenal metastases in hormone-refractory prostate cancer.
    Kohli M; Viswamitraa S; Schaefer R; Faas FH; Kumar U
    Clin Adv Hematol Oncol; 2006 Oct; 4(10):754-5; discussion 756-7. PubMed ID: 17099632
    [No Abstract]   [Full Text] [Related]  

  • 17. [Primary fibrinolysis and adenocarcinoma of the prostate: presentation of 2 cases].
    López Jiménez L; Martín Martín F; Martín Jiménez T; Angel Rodríguez Marcos M; Montes Santiago J; Cuervas-Mons Martínez V; Moya Mir MS; Barbadillo García de Velasco R
    Med Clin (Barc); 1984 Nov; 83(15):637-9. PubMed ID: 6521517
    [No Abstract]   [Full Text] [Related]  

  • 18. Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens.
    Cheng L; Poulos CK; Pan CX; Jones TD; Daggy JK; Eble JN; Koch MO
    J Urol; 2005 Sep; 174(3):898-902. PubMed ID: 16093983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological changes of high-grade prostatic intraepithelial neoplasia and prostate cancer after monotherapy with bicalutamide 150 mg.
    Scattoni V; Montironi R; Mazzucchelli R; Freschi M; Nava L; Losa A; Terrone C; Scarpa RM; Montorsi F; Pappagallo G; Rigatti P
    BJU Int; 2006 Jul; 98(1):54-8. PubMed ID: 16831143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorrect biochemistry complicates prostate cancer management.
    McAuley I; Steinhoff G; McNeely M; Blood P
    Can J Urol; 2002 Apr; 9(2):1496-7. PubMed ID: 12010595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.